RAPIDITY OF SYMPTOM CONTROL WITH UPADACITINIB INDUCTION THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM TWO RANDOMIZED PHASE 3 STUDIES

Ken Takeuchi  1     Xiang Gao  2     Remo Panaccione  3     Silvio Danese  4     Dapo Ilo  5     Tricia Finney-Hayward  5     Wen Zhou  5     Charles Phillips  5     Xuan Yao  5     Severine Vermeire  6    
1 Tsujinaka Hospital Kashiwanoha, Kashiwa, Japan
2 The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
3 University of Calgary, Calgary, Canada
4 Humanitas University and Humanitas Research Hospital, Milan, Italy
5 AbbVie Inc., North Chicago, United States
6 University Hospital Leuven, Leuven, Belgium

Topic
IBD

Session
IBD: Clinical trials II (small molecules)

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)

Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing